Louisiana firm opens new office in Capital City
by MBJ Staff
Published: October 23,2011
JACKSON — Chaffe & Associates Inc. of New Orleans has opened a full-service office in Jackson. Through this office, Chaffe will provide investment banking and advisory services to public and private businesses and community banks in Mississippi, including business valuation services for purposes such as estate planning, ESOPs and fair value accounting.
John P. Hammond, former vice president of finance for Jackson-based SmartSynch Inc. and CFO for American HealthTech, has joined the firm and will operate out of the Jackson office. Vanessa Brown Claiborne, President and CEO of Chaffe, noted, “Chaffe has an extensive track record in helping business owners throughout the Gulf South achieve their strategic objectives. We are especially excited to have John join us to help us more closely serve the Mississippi business community.”
Leland R. Speed, interim executive director of the Mississippi Development Authority, said, “Chaffe & Associates has a very strong reputation in investment banking and I welcome them to Jackson. Our state’s economy will benefit from having a local investment banker with their level of expertise.”
To sign up for Mississippi Business Daily Updates, click here.
Twang & Tourism: The Country Music Trail
Still planning that summer vacation?
FOLLOW THE MBJ ON TWITTERMy Tweets
Top Posts & Pages
- Prescription for success — Transcript Pharmacy continues fast growth
- Study: Mississippi has highest sales tax rate in U.S.
- MSU researchers develop timber-management software
- Panther Creek megasite — Putting a value proposition out there
- New law on taxing methods hailed as big win for businesses
- Nehi Bottling Company has been a Cleveland fixture for 85 years
- BBB issues warning involving asphalt paving scam
- Running luxury car dealerships, like Mercedes of Jackson, comes naturally to Trudy Higginbotham Moody
- Baker Donelson's David A. Rueff Jr. co-authors guide
- Panther Creek's location in medical industry zone boosts bio-med prospects